Use of myostatin (GDF8) inhibitors in conjunction with corticosteroids for treating neuromuscular disorders

Details for Australian Patent Application No. 2004245025 (hide)

Owner Wyeth

Inventors Li, Xiangping; Whittemore, Lise-Anne

Agent Cullen & Co

Pub. Number AU-A-2004245025

PCT Pub. Number WO2004/108157

Priority 60/474,603 02.06.03 US

Filing date 1 June 2004

Wipo publication date 16 December 2004

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 21/00 (2006.01) Drugs for disorders of the muscular or neuromuscular system

Event Publications

22 December 2005 PCT application entered the National Phase

  PCT publication WO2004/108157 Priority application(s): WO2004/108157

29 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  Application withdrawn under section 141(1). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004245028-Drug delivery device and method for bidirectional drug delivery

2004245023-Bone plate